InvestorsHub Logo
Followers 22
Posts 3682
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Wednesday, 08/07/2024 6:39:55 AM

Wednesday, August 07, 2024 6:39:55 AM

Post# of 3059
My daughter, Little FLO, found this on X August 6 -

Congratulations to members of Team Enanta for their publication in
@NatureComms
highlighting the preclinical data of EDP-235, Enanta’s 3CL protease inhibitor, in development for the treatment of #COVID-19. Thanks to everyone who made this publication possible and to first author Michael Rhodin who gives us permission to share this link.

Article Published: 01 August 2024
The small molecule inhibitor of SARS-CoV-2 3CLpro EDP-235 prevents viral replication and transmission in vivo

https://www.nature.com/articles/s41467-024-50931-8. This is the full, in-depth article - FANTASTIC!!

Thanks to biocqr for the original heads-up.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News